Commentary

In the first year of his experience as a columnist, Dr. Ogan Gurel has devoted considerable newsprint to technology convergence and its impact on the healthcare industry. In this edition of MedTech Futures, he explains how compatible this trend is with the move to personalized...

For companies that are hunting for that sometimes elusive angel or venture capital, it all comes down to the term sheet, according to Private Placements columnist Matt Storms. He devotes the latest installment of this capital raising advice column to the finer points of the...

It's difficult to find attorneys in Wisconsin who are willing to comment on the stem cell patents held by the Wisconsin Alumni Research Foundation, but WTN has located a couple of patent experts who have some encouraging news from WARF's perspective. Despite a strong challenge...

Do we really need workers from overseas, or do we need to re-employ those that have lost IT and tech jobs in the last five years?” asks columnist James Carlini. In this edition of Carlini's Comments, he talks about the salary-slicing impact of luring H-1B...

Just by looking at the numbers, the vast potential of the Indian market should get the attention of every American state that wants to engage in foreign trade. Yer Biotech Blues columnist Michael Rosen recently took a trip to India with an Illinois trade delegation,...

Customer engagement is the mantra of new and aggressive attempts to reach the public through new-media concepts. In this edition of Buzz Networks, columnist Paul Gibler looks at four companies that have revamped their approach and now are using web-based media to good effect....

Has your network infrastructure plan collapsed? asks columnist James Carlini. If so, the author of Carlini's Comments points to Fort Wayne, Ind. as a community that is both “wired and inspired,” and he advises Midwestern states to drive a hard bargain with “telcos” that want...